Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Attenuated Mumps Vaccine (Human Diploid Cell)

NCT03133923 is registered in ClinicalTrials.gov with Institute of Medical Biology, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT03133923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03133923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Attenuated Mumps Vaccine (Human Diploid Cell)
Lead sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Phase
Phase 2
Overall status
Unknown status
Start date
May 20, 2017
Completion date
July 1, 2024
Enrollment
1,080 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epidemic parotitis,mumps